🔗 Permalink

Inventor profile of:

Thomas Thum

City:

Hannover

Country:

Germany

Published Applications:

Last publication date:

2026-04-30

Top Assignees for applications by Thomas Thum

The entities that hold a legal rights for patent applications filed by inventor Thum Thomas:

MEDIZINISCHE HOCHSCHULE HANNOVER 10 Hannover, Germany
JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG 9 WURZBURG, Germany
MEDIZINISCHE HOCHSHULE HANNOVER 1 Hannover, Germany
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. 1 Munich, Germany
INSTITUT PASTEUR DE LILLE (IPL) 1 Lille, France
Julius-Maximilans-Universitat Wurzburg 1 Wurzburg, Germany
JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG 1 Würzburg, Germany
MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN e.V. 1 Muenchen, Germany
JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG 1 Wuerzburg, Germany
Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V. 1 Munchen, Germany
Medizinische Hochschule Hannover (MHH) 1 Hannover, Germany
UNIVERSITÉ DE LILLE 2 (LILLE 2)—UNIVERSITY OF LAW AND HEALTH 1 Lille, France
CENTRE HOSPITALIER UNIVERSITAIRE LILLE (CHU) 1 Lille, France
ST. JOSEF - UND ST. ELISABETH HOSPITAL GMBH 1 Bochum, Germany
Novo Nordisk A/S 1 Bagsvaerd, Denmark
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE- INSERM 1 Paris, France

Recent patent applications by Thum Thomas

Thomas Thum from Hannover, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-30

US20260117226A1

Chemistry; metallurgy

LONG NON-CODING RNAS AS TARGET FOR TREATING FIBROSIS AND CANCER

#2 | 2024-06-13

US20240189339A1

Human necessities

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

#3 | 2023-07-27

US20230235403A1

Chemistry; metallurgy

LONG NON-CODING RNA AS THERAPEUTIC TARGET IN CARDIAC DISORDERS AND CARDIAC REGENERATION

#4 | 2023-03-09

US20230074198A1

Chemistry; metallurgy

Viral vector particle based on AA V2 for gene therapy

#5 | 2023-01-26

US20230028937A1

Human necessities

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

#6 | 2022-11-03

US20220348920A1

Chemistry; metallurgy

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

#7 | 2022-10-06

US20220315924A1

Chemistry; metallurgy

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

#8 | 2022-08-04

US20220243204A1

Chemistry; metallurgy

TREATMENT OF HEART FAILURE IN HUMAN SUBJECTS

#9 | 2022-05-26

US20220162597A1

Chemistry; metallurgy

Compound for treatment of heart failure

#10 | 2021-06-17

US20210180054A1

Chemistry; metallurgy

Compound for treatment of heart failure

#11 | 2021-04-22

US20210113603A1

Human necessities

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

#12 | 2020-05-28

US20200165604A1

Chemistry; metallurgy

LncRNAs for therapy and diagnosis of cardiac hypertrophy

#13 | 2020-03-05

US20200069720A1

Human necessities

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

#14 | 2019-12-12

US20190376061A1

Chemistry; metallurgy

IncRNAS for therapy and diagnosis of angiogenesis

#15 | 2019-11-21

US20190350923A1

Human necessities

Natural compounds and fibrosis

#16 | 2019-05-09

US20190136236A1

Chemistry; metallurgy

LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling

#17 | 2018-12-20

US20180360866A1

Human necessities

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#18 | 2017-10-26

US20170304347A1

Human necessities

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#19 | 2017-08-24

US20170240969A1

Chemistry; metallurgy

A CIRCULATING NON-CODING RNA AS PREDICTOR OF MORTALITY IN PATIENTS WITH ACUTE KIDNEY INJURY

#20 | 2017-06-29

US20170183652A1

Chemistry; metallurgy

LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY

#21 | 2017-04-27

US20170114409A1

Chemistry; metallurgy

Mitochondrial non-coding RNAs for predicting disease progression in heart failure and myocardial infarction patients

#22 | 2017-02-09

US20170037405A1

Chemistry; metallurgy

LncRNAs for therapy and diagnosis of angiogenesis

#23 | 2016-06-23

US20160177391A1

Chemistry; metallurgy

ANALYSIS FOR TAKOTSUBO CARDIOMYOPATHY BY MEANS OF DIFFERENTIALLY REGULATED MICRORNA MOLECULES

#24 | 2016-06-23

US20160177302A1

Chemistry; metallurgy

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#25 | 2015-09-24

US20150267254A1

Chemistry; metallurgy

MICRORNA PROFILES IN THE DIAGNOSIS OF MULTIPLE SCLEROSIS

#26 | 2014-09-18

US20140275220A1

Chemistry; metallurgy

miRNA-212/132 family as a therapeutic target

#27 | 2014-05-01

US20140121264A1

Human necessities

Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposes

#28 | 2013-01-17

US20130018084A1

Human necessities

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#29 | 2012-08-09

US20120202201A1

Chemistry; metallurgy

DEVICE AND METHOD FOR ANALYSIS OF KIDNEY FAILURE

#30 | 2012-07-12

US20120180147A1

Chemistry; metallurgy

MicroRNA-24

#31 | 2011-03-24

US20110071211A1

Human necessities

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

#32 | 2006-11-16

US20060258632A1

Human necessities

Methods and agents for treating cardiovascular diseases

InventorID:

42629 ⎘